Navigation Links
AANMA Announces Launch of Free Web-Based Education Program for Patients Transitioning From CFC to HFA Inhalers
Date:12/3/2008

FAIRFAX, Va., Dec. 3 /PRNewswire-USNewswire/ -- Allergy & Asthma Network Mothers of Asthmatics (AANMA) announced today that a new Web-based video geared to help people successfully manage the transition from CFC albuterol inhalers to HFA inhalers is now available at its Web site, www.breatherville.org. Smart Moves to an HFA Inhaler uses technology that allows viewers to ask questions in everyday language and immediately receive a response with relevant, highly focused answers. Users can obtain valuable information about why inhalers are changing, the differences between newer and older inhalers, cost concerns and how to use new HFA inhalers.

"We created this video to help patients and their families learn more about this federal mandate, as a significant number of patients are still not aware of how to safely go about making this change," said Nancy Sander, president and founder of AANMA. "At the end of the year, inhalers are changing. These changes are mandatory, and there are important decisions to make about treatment options that require thoughtful consideration of the patient's medical history and current respiratory health status."

In less than 30 days, life-saving albuterol inhalers used by nearly 40 million patients with respiratory disorders will no longer be sold. After December 31, 2008, it will no longer be permissible to manufacture or sell albuterol inhalers in the United States that contain chlorofluorocarbon (CFC) propellants, because they destroy the Earth's ozone layer. These inhalers have been replaced with four distinct non-CFC propelled alternatives, which contain hydrofluoroalkane (HFA) propellant.

While the transition has been forthcoming for some time, data from IMS Health show that an estimated 14 million CFC prescriptions have yet to be transitioned to HFA MDIs.(1) The absence of a medically responsible transition protocol leaves patients unknowingly exposed to health risks beyond their control.

Patients with asthma, COPD and other respiratory conditions use albuterol at the first sign of symptoms, before exercise and when experiencing breathing exacerbations. Because there are significant differences between CFC and HFA inhalers, patients and medical professionals need to have the opportunity to make the switch in a medically responsible way.

The Web module is hosted by former CNN Medical correspondent Rea Blakey, and supported by an educational grant from Sepracor.

For more information about the MDI transition, please visit AANMA's MDI Transition Web page at www.mditransition.org. Patients seeking information can also call AANMA's Patient Support Center at 800-315-8056.

About AANMA

Founded in 1985, Allergy & Asthma Network Mothers of Asthmatics is the leading national nonprofit family organization dedicated to eliminating suffering and death due to asthma, allergies and related conditions. AANMA's core areas of expertise are education, advocacy and outreach. Call 800.878.4403 or visit www.breatherville.org.

(1) IMS NPA, August 22, 2008


'/>"/>
SOURCE Allergy & Asthma Network Mothers of Asthmatics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lucas Group Announces Their Executive Recruitment Military Hiring Conference Schedule for December 2008
2. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
3. United American Healthcare Corporation Announces Stock Repurchase Program
4. eOn Communications Announces GSA Contract
5. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
6. USHIFU Announces First Sonablate(R) HIFU Device in India for Minimally Invasive Prostate Cancer Treatment
7. Elsevier announces the 2008 supplement of Reproductive Health Matters
8. Pascal Metrics Announces Patient Safety Culture Services Offering
9. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
10. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
11. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... NEW ORLEANS (PRWEB) , ... February 11, 2016 , ... ... : Achieving Satisfaction through a Well Managed Mind” (published by Balboa Press) teaches readers ... unique way of being through profound love, author Janice McDermott, M.Ed., LCSW, offers an ...
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western University of ... Program Tuesday, February 9, taking one of the final steps in their medical ... positions across the country. Of the 103 student-doctors who comprise the College of ...
(Date:2/11/2016)... ... 2016 , ... Florida Hospital presents Heart Health Awareness night on Sunday February ... the Amalie Arena. The puck drops at 6:00pm, but fans will have the opportunity ... to the game. The MEGA Heart will be located on Ford Thunder Alley and ...
(Date:2/11/2016)... Alexandria, Va. (PRWEB) , ... February 11, 2016 , ... ... for the DoD Military Health System but would shift more of the cost burden ... described the TRICARE-reform plan laid out in the defense budget as including limited quantifiable ...
(Date:2/11/2016)... ... February 11, 2016 , ... Pediatric cardiovascular surgeons, cardiologists ... by making data on heart procedures public and easily understandable for families and ... Reporting of Pediatric and Congenital Heart Disease Outcomes will bring hundreds of pediatric ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016  Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces the engagement of Lars E. ... Medical Consultant. Dr. Birgerson will provide strategic medical ... operations team to help ensure timely facilitation of ...
(Date:2/11/2016)... 11, 2016 SI-BONE, Inc., a medical ... iFuse Implant System, a minimally invasive surgical (MIS) ... the sacroiliac (SI) joint, announced the publication of ... MIS SI joint fusion for patients suffering from ... or SI joint disruption.  In the first article, ...
(Date:2/11/2016)... CARLSBAD, Calif. , Feb.11, 2016  Ionis Pharmaceuticals, Inc. ... a live webcast on Thursday, February 25 at 11:30 a.m. ... on pipeline and business progress. www.ionispharma.com . ... at the same address. --> www.ionispharma.com . A ... the same address. --> Interested parties may listen ...
Breaking Medicine Technology: